preTIME: The Prevalence and Incidence of DVT in General ICU

Sponsor
Masaryk Hospital Krajská zdravotní a.s. (Other)
Overall Status
Completed
CT.gov ID
NCT03286985
Collaborator
(none)
200
1
4
50.3

Study Details

Study Description

Brief Summary

Deep venous thrombosis (DVT) represents a major problem in intensive care unit (ICU) patients. Despite the use of recommended pharmacological prophylaxis with low molecular weight heparin (LMWH), the incidence of DVT during ICU stay has been reported between 5 and 15 %. The incidence may vary due to many factors, for example the type of ICU population, the type of protocol of pharmacological prophylaxis and also the type of diagnostic approach. Before formerly planned clinical study targeted to lower DVT incidence by individualizing the dose of LMWH, the investigators decided to evaluate the real DVT incidence in the investigated ICU. The prevalence and incidence will be assessed by ultrasound testing in general ICU patients. on the sample of 200 patients. The investigators hypothesize DVT incidence of 5 %. The compliance to the local DVT prophylaxis protocol will be also evaluated.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Type of the study: Observational prospective cohort study. Hypothesis: Despite appropriate prophylaxis of deep venous thrombosis in general ICU patients in accordance with the current guidelines, the incidence of deep venous thrombosis is 5 - 10%.

    Sample size: 200 consecutive general ICU patients. Inclusion and exclusion criteria: defined in the Eligibility section. Protocol description: All patients admitted to ICU with expected period of the stay longer than 72 hours will be evaluated for the presence of deep venous thrombosis by ultrasound testing during the first 48 hours of ICU stay. Thereafter, each participant will be examined by ultrasound testing twice a week until the discharge from ICU. All patients will receive deep venous thrombosis prophylaxis following the current guidelines. All patients with positive finding of deep venous thrombosis will be managed in accordance with the current guidelines.

    Ultrasound examination for deep venous thrombosis: Ultrasound compression test at the following locations: common femoral vein at the groin, deep femoral vein, popliteal vein, both extremities.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Prevalence and Incidence of Deep Venous Thrombosis in General ICU Patients Receiving Enoxaparine Prophylaxis
    Actual Study Start Date :
    Sep 1, 2017
    Actual Primary Completion Date :
    Dec 31, 2017
    Actual Study Completion Date :
    Dec 31, 2017

    Arms and Interventions

    Arm Intervention/Treatment
    General ICU patients

    No intervention is associated with inclusion to the study (observational study). Included will be all patients admitted to general ICU with ICU stay >72 hours, having deep venous thrombosis prophylaxis appropriate to clinical setting and following the recent guidelines. All study participants will undergo repeated noninvasive ultrasound testing for deep venous thrombosis, which is normal part of the routine care in our ICU.

    Outcome Measures

    Primary Outcome Measures

    1. Incidence of deep venous thrombosis [24 hours from ICU admission to ICU discharge (up to 12 month)]

      Number of patients with new onset deep venous thrombosis diagnosed during ICU stay (ie deep venoous thrombosis developed after the first 24 hours of ICU stay)

    Secondary Outcome Measures

    1. Prevalence of deep venous thrombosis [From ICU admission to ICU discharge (up to 12 month)]

      A number of patients with deep venous thrombosis diagnosed anytime during ICU stay (on admission and during ICU stay)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    All general ICU patients meeting exclusion and inclusion criteria.

    Inclusion criteria:
    1. General ICU patient with expected length of stay more than 72 hours
    Exclusion Criteria:
    1. Inability to perform ultrasound investigation for deep venous thrombosis (for medical or technical reasons)

    2. ICU stay shorter than 72 hours

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Masaryk Hospital Ústí nad Labem Česká Republika Czechia 40011

    Sponsors and Collaborators

    • Masaryk Hospital Krajská zdravotní a.s.

    Investigators

    • Principal Investigator: Jan Beneš, MD, Department of Anesthesiology, Perioperative Medicine and Intensive Care, J.E. Purkinje University, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jan Benes, MUDr. Ing., Masaryk Hospital Krajská zdravotní a.s.
    ClinicalTrials.gov Identifier:
    NCT03286985
    Other Study ID Numbers:
    • 236/60
    First Posted:
    Sep 19, 2017
    Last Update Posted:
    Oct 19, 2020
    Last Verified:
    Mar 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 19, 2020